v3.26.3
Net Income (Loss) Per Share (Tables)
9 Months Ended
Sep. 30, 2026
Net Income (Loss) Per Share [Abstract]  
Schedule of Basic and Diluted Net Income (Loss) Per Share

The components of basic and diluted net income (loss) per share were as follows:

 

    Three months ended
September 30,
    Nine months ended
September 30,
 
(In thousands, except share and per share data)   2026     2025     2026     2025  
Numerator:                        
Net (loss) income from continuing operations   $ (533 )   $ (10,633 )   $ 20,573     $ (21,112 )
Net (loss) income from discontinued operations     —       (32 )     —       1,461  
Minus: net income (loss) allocated to participating warrants     —       —       (14,264 )     —  
Numerator for basic EPS - Net (loss) income available for common shareholders   $ (533 )   $ (10,665 )   $ 6,309     $ (19,651 )
                                 
Effect of dilutive securities                                
                                 
Interest expense on Convertible Notes - from continuing operations   $ —     $ —     $ 4,440     $ —  
Change in fair value of liability-classified warrants     —       —       (12 )     —  
Reallocation of net income to participating warrants     —       —       152       —  
Numerator for diluted EPS - Net (loss) income available for common shareholders   $ (533 )   $ (10,665 )   $ 10,889     $ (19,651 )
                                 
Denominator:                                
Denominator for basic EPS - Weighted-average common shares outstanding     7,722,524       2,002,568       4,029,540       1,973,553  
Effect of dilutive securities                                
Unvested restricted stock units     —       —       —       —  
Liability-classified warrants     —       —       32,106       —  
Conversion of Convertible Notes     —       —       2,947,143       —  
Denominator for diluted EPS - adjusted weighted-average common stock outstanding     7,722,524       2,002,568       7,008,789       1,973,553  
Basic net (loss) income per share attributable to common shareholders   $ (0.07 )   $ (5.33 )   $ 1.57     $ (9.96 )
Diluted net (loss) income per share attributable to common shareholders   $ (0.07 )   $ (5.33 )   $ 1.55     $ (9.96 )
Schedule of Anti-Dilutive Shares the Company excluded the following potential common stock equivalents, presented based on amounts outstanding at each period end, from the computation of diluted earnings (loss) per share attributable to common stockholders for the periods presented because their inclusion would have been anti-dilutive.

 

    Nine months ended
September 30,
 
    2026     2025  
Shares subject to outstanding warrants     7,708       7,641,863  
Shares subject to unvested restricted stock units     124,750       82,000  
Shares subject to outstanding stock options     75       75  
      132,533       7,723,938